Devices that lack adequate clinical validation pose risks for patient care. A new validation standard is proposed to evaluate FDA authorization as an indication of clinical effectiveness in medical AI.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Beyond models: a paradigm shift toward human-centered AI system design
Critical Care Open Access 03 December 2025
-
Exploring nurse perspectives on AI-based shift scheduling for fairness, transparency, and work-life balance
BMC Nursing Open Access 02 September 2025
-
How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations
npj Digital Medicine Open Access 01 July 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Change history
16 September 2024
A Correction to this paper has been published: https://doi.org/10.1038/s41591-024-03293-z
References
Murphy, K. et al. BMC Med. Ethics 22, 14 (2021).
Kim, J. Y. et al. In FAccT '23: Proc. 2023 ACM Conference on Fairness, Accountability, and Transparency 1396–1417 (2023).
Geis, J. R. et al. Can. Assoc. Radiol. J. 70, 329–334 (2019).
Evans, B. J. J. Law Biosci. 10, lsad001 (2023).
Vellido, A. Kidney Dis. 5, 11–17 (2018).
Center for Devices and Radiological Health. FDA https://go.nature.com/4dDbUct (6 September 2023).
US Food and Drug Administration. https://go.nature.com/3YN8Civ (14 October 2016).
US Food and Drug Administration. https://go.nature.com/3LYd32i (September 2023).
US Food and Drug Administration. https://go.nature.com/3SOXHRw (accessed 17 September 2023).
Lyell, D., Wang, Y., Coiera, E. & Magrabi, F. J. Am. Med. Inform. Assoc. 30, 1227–1236 (2023).
US Food and Drug Administration. https://go.nature.com/3YwMt87 (accessed 14 June 2023).
Kalantaridis, C. & Küttim, M. J. Technol. Transfer 46, 1487–1513 (2021).
MIT News Office. https://go.nature.com/3LVzBkb (7 September 2017).
Sandhu, S. et al. Patterns 4, 100710 (2023).
Tierney, W. M., Meslin, E. M. & Kroenke, K. J. Gen. Intern. Med. 31, 228–233 (2016).
Harris, P., Winney, I., Ashhurst-Smith, C., O'Brien, M. & Graves, S. Pathology 44, 583–585 (2012).
Wu, E. et al. Nat. Med. 27, 582–584 (2021).
Acknowledgements
For their consultation, comments and mentorship, the authors thank M. R. Patel, W. Ratliff, Z. Hussain, J. Castillo, I. Yüksel, H. Chen, P. Guo, H. McInnis, J. E. Hancock, B. J. Evans and A. Merlo.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Chouffani El Fassi, S., Abdullah, A., Fang, Y. et al. Not all AI health tools with regulatory authorization are clinically validated. Nat Med 30, 2718–2720 (2024). https://doi.org/10.1038/s41591-024-03203-3
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41591-024-03203-3
This article is cited by
-
Application of artificial intelligence in the diagnosis of malignant digestive tract tumors: focusing on opportunities and challenges in endoscopy and pathology
Journal of Translational Medicine (2025)
-
Beyond models: a paradigm shift toward human-centered AI system design
Critical Care (2025)
-
Exploring nurse perspectives on AI-based shift scheduling for fairness, transparency, and work-life balance
BMC Nursing (2025)
-
Guiding responsible AI in healthcare in the Philippines
npj Digital Medicine (2025)
-
Situating governance and regulatory concerns for generative artificial intelligence and large language models in medical education
npj Digital Medicine (2025)